SCHEMBL6137989

SCHEMBL6137989

N=C(N)N(CC(S)Cc1ccccc1)C(=O)c1ccc(Cl)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGER Q15109 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.40
MAPT P10636 1/20 0.40
PPARG P37231 3/20 0.39
PPARA Q07869 3/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
GRIN2B Q13224 1/20 0.38
PSMB8 P28062 1/20 0.38
PSMB5 P28074 1/20 0.38
HTT P42858 1/20 0.38
ALPI P09923 1/20 0.37
PKM P14618 1/20 0.37
PTGS1 P23219 1/20 0.37
XIAP P98170 1/20 0.37
SLC7A5 Q01650 1/20 0.37
CHRM2 P08172 1/20 0.37
CHRM3 P20309 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6137977 0.80 AGER (0.54) AGERL3MBTL1MAPTNPC1RAB9A
SCHEMBL6137934 0.75 SCN5A (0.49) AGERL3MBTL1MAPTNPC1RAB9A
SCHEMBL6137987 0.74 L3MBTL1 (0.48) AGERL3MBTL1MAPTNPC1RAB9A
SCHEMBL6137702 0.67 MEN1 (0.47) L3MBTL1MAPTNPC1RAB9AGRIN2B
Fenclonine SCHEMBL28422788 0.65 SLC7A5 (0.79) MAPTPPARGPPARAALPIPKM
Fenclonine SCHEMBL8497239 0.65 SLC7A5 (0.79) MAPTPPARGPPARAALPIPKM
SCHEMBL7332659 0.65 BLM (0.42) L3MBTL1MAPTGRIN2BPKMMEN1
SCHEMBL4133545 0.64 EPHX1 (0.50) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL6137843 0.64 TDP1 (0.45) MAPTNPC1RAB9AGRIN2BKMT2A
SCHEMBL6137828 0.64 ACHE (0.56) L3MBTL1NPC1RAB9AHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1032556-A4 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE CAMBRIDGE NEUROSCIENCE INC (US) 2005-02-02 EP claimed
EP-1032556-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE CAMBRIDGE NEUROSCIENCE, INC. (US) 2000-09-06 EP claimed
WO-1999020599-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE CAMBRIDGE NEUROSCIENCE, INC. (US) 1999-04-29 WO claimed